Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis.

[1]  S. Naito,et al.  Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. , 2006, The Journal of urology.

[2]  L. Guillou,et al.  Alpha-methyl CoA racemase expression in renal cell carcinomas. , 2006, Human pathology.

[3]  S. Suster,et al.  High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants , 2006, Modern Pathology.

[4]  J. Srigley,et al.  Immunohistochemical Analysis of Mucinous Tubular and Spindle Cell Carcinoma and Papillary Renal Cell Carcinoma of the Kidney: Significant Immunophenotypic Overlap Warrants Diagnostic Caution , 2006, The American journal of surgical pathology.

[5]  Markku Miettinen,et al.  KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation , 2005, Applied immunohistochemistry & molecular morphology : AIMM.

[6]  L. Sobin,et al.  TNM Atlas : Illustrated Guide to the TNM Classification of Malignant Tumours , 2005 .

[7]  A. Folpe,et al.  Distribution of Cytokeratins and Vimentin in Adult Renal Neoplasms and Normal Renal Tissue: Potential Utility of a Cytokeratin Antibody Panel in the Differential Diagnosis of Renal Tumors , 2005, The American journal of surgical pathology.

[8]  T. Ogawa,et al.  Composite distal nephron‐derived renal cell carcinoma with chromophobe and collecting duct carcinomatous elements , 2005, Pathology international.

[9]  C. Langner,et al.  Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas , 2005, BJU international.

[10]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[11]  C. Pan,et al.  A distinct expression pattern and point mutation of c-KIT in papillary renal cell carcinomas , 2004, Modern Pathology.

[12]  C. Pan,et al.  The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases , 2004, Histopathology.

[13]  J. Verbavatz,et al.  Collecting duct carcinoma: an entity to be redefined? , 2004, Virchows Archiv.

[14]  E. Lee,et al.  A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas , 2004, Modern Pathology.

[15]  B. Mellado,et al.  KIT Expression in Chromophobe Renal Cell Carcinoma: Comparative Immunohistochemical Analysis of KIT Expression in Different Renal Cell Neoplasms , 2004, The American journal of surgical pathology.

[16]  A. Papanikolaou,et al.  KIT expression in fetal, normal adult, and neoplastic renal tissues , 2004, Journal of Clinical Pathology.

[17]  F. Erdoğan,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 2004, International journal of clinical practice.

[18]  Ximing J. Yang,et al.  Expression of Alpha-Methylacyl-CoA Racemase in Papillary Renal Cell Carcinoma , 2004, The American journal of surgical pathology.

[19]  H. Enzan,et al.  Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. , 2003, Histology and Histopathology.

[20]  Tsutomu Ohta,et al.  Overexpression of KIT in chromophobe renal cell carcinoma , 2003, Oncogene.

[21]  S. Kim,et al.  Immunohistochemical Profile of Common Epithelial Neoplasms Arising in the Kidney , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[22]  H. Enzan,et al.  Review of collecting duct carcinoma with focus on clinical and pathobiological aspects. , 2002, Histology and histopathology.

[23]  T. Shuin,et al.  Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters , 2002, Genes, chromosomes & cancer.

[24]  Y. Nagashima.  Chromophobe renal cell carcinoma: Clinical, pathological and molecular biological aspects , 2000, Pathology international.

[25]  G. Mannaerts,et al.  Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans. , 2000, Journal of lipid research.

[26]  S. Ferdinandusse,et al.  Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. , 2000, Journal of lipid research.

[27]  A. Renshaw,et al.  Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. , 2000, The American journal of surgical pathology.

[28]  Y. Nagashima,et al.  Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. , 1999, Modern Pathology.

[29]  J. Srigley,et al.  Collecting duct carcinoma of kidney. , 1998, Seminars in diagnostic pathology.

[30]  B. Delahunt,et al.  Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[31]  BMC Urology BioMed Central , 2003 .

[32]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .

[33]  P. Hermanek.  TNM atlas : Illustrated guide to the TNM/pTNM classification of malignant tumours , 1997 .